Atlas Trials

The Study of BGB-283 in Chinese Subjects With Local Advanced or Metastatic Malignant Solid Tumor

Clinical trial NCT03641586 · COMPLETED

Trial details

NCT number
NCT03641586
Sponsor
BeiGene
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumors
Start date
2015-10-12
Primary completion
2016-12-06
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.